Pharma BD Deal Intelligence
Merck KGaA acquired Sigma-Aldrich for $17B for life science.
Merck KGaA closed on the $17.0 billion purchase of research-chemical supply house Sigma-Aldrich, an even larger laboratory supply combination than Thermo…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Merck KGaA acquired Sigma-Aldrich for $17B for life science.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Merck KGaA / Sigma-Aldrich Corporation (this deal) | 2014 | $17.0B | 80 |
| Merck KGaA / Millipore Corporation | 2010 | $7.2B | 88 |
| Merck KGaA / Versum Materials | 2019 | $5.8B | 80 |
| Merck KGaA / Serono SA | 2006 | $13.2B | 74 |
| Merck KGaA / SpringWorks Therapeutics | 2025 | $3.4B | 72 |
| Merck KGaA / Threshold Pharmaceuticals, Inc. | 2012 | $550M | — |
| Merck KGaA / Debiopharm | 2021 | $1.1B | — |
← Browse all deals · How we score deals
More: 2014 deals · Merck KGaA deals · Multiple (undisclosed) deals